BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36304051)

  • 41. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integration of HIV pre-exposure prophylaxis (PrEP) services for pregnant and breastfeeding women in eight primary care clinics: results of an implementation science study.
    Nelson A; Bheemraj K; Dean SS; de Voux A; Hlatshwayo L; Mvududu R; Berkowitz N; Neumuller C; Jacobs S; Fourie S; Coates T; Bekker LG; Myer L; Davey DJ
    Res Sq; 2023 Nov; ():. PubMed ID: 38045335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-exposure Prophylaxis Implementation in Family Planning Services Across the Southern United States: Findings from a Survey Among Staff, Providers and Administrators Working in Title X-Funded Clinics.
    Sales JM; Escoffery C; Hussen SA; Haddad LB; McCumber M; Kwiatkowski E; Filipowicz T; Sanchez M; Psioda MA; Sheth AN
    AIDS Behav; 2021 Jun; 25(6):1901-1912. PubMed ID: 33483899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceptability of HIV self-testing to support pre-exposure prophylaxis among female sex workers in Uganda and Zambia: results from two randomized controlled trials.
    Ortblad KF; Chanda MM; Musoke DK; Ngabirano T; Mwale M; Nakitende A; Chongo S; Kamungoma N; Kanchele C; Bärnighausen T; Oldenburg CE
    BMC Infect Dis; 2018 Oct; 18(1):503. PubMed ID: 30286737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
    Beesham I; Joseph Davey DL; Beksinska M; Bosman S; Smit J; Mansoor LE
    AIDS Behav; 2022 Aug; 26(8):2623-2631. PubMed ID: 35122575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
    Ong JJ; Fu H; Baggaley RC; Wi TE; Tucker JD; Smith MK; Rafael S; Falconer J; Terris-Prestholt F; Mameletzis I; Mayaud P
    J Int AIDS Soc; 2021 Feb; 24(2):e25673. PubMed ID: 33605081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrating reproductive health services into HIV care: strategies for successful implementation in a low-resource HIV clinic in Lilongwe, Malawi.
    Phiri S; Feldacker C; Chaweza T; Mlundira L; Tweya H; Speight C; Samala B; Kachale F; Umpierrez D; Haddad L;
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):17-23. PubMed ID: 25902815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementation and resource needs for long-acting PrEP in low- and middle-income countries: a scoping review.
    Castor D; Heck CJ; Quigee D; Telrandhe NV; Kui K; Wu J; Glickson E; Yohannes K; Rueda ST; Bozzani F; Meyers K; Zucker J; Deacon J; Kripke K; Sobieszczyk ME; Terris-Prestholt F; Malati C; Obermeyer C; Dam A; Schwartz K; Forsythe S
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26110. PubMed ID: 37439063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
    Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
    J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs.
    Grimshaw C; Boyd L; Smith M; Estcourt CS; Metcalfe R
    HIV Med; 2021 Nov; 22(10):965-970. PubMed ID: 34585494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol.
    De Baetselier I; Reyniers T; Nöstlinger C; Wouters K; Fransen K; Crucitti T; Kenyon C; Buyze J; Schurmans C; Laga M; Vuylsteke B;
    JMIR Res Protoc; 2017 Jan; 6(1):e11. PubMed ID: 28135199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial.
    Kawichai S; Songtaweesin WN; Wongharn P; Phanuphak N; Cressey TR; Moonwong J; Vasinonta A; Saisaengjan C; Chinbunchorn T; Puthanakit T
    JMIR Mhealth Uhealth; 2022 Apr; 10(4):e25561. PubMed ID: 35451976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Men targeted for family planning in Zambia.
    Chirambo K
    Netw Res Triangle Park N C; 1992 Aug; 13(1):16-7. PubMed ID: 12317722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
    Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
    Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care.
    Pilgrim N; Jani N; Mathur S; Kahabuka C; Saria V; Makyao N; Apicella L; Pulerwitz J
    PLoS One; 2018; 13(4):e0196280. PubMed ID: 29702659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.